OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS by T. V. Dokukina, M. V. Makhrov, I. V. Gaidukevich, A. A. Gilep, T. S. Golubeva, F. P. Khlebokazov, N. N. Misyuk, P. P. Korolevich

Get full text

Evaluation of the effectiveness of electroconvulsive therapy in the treatment of psychosis in a patient with epilepsy. Clinical case by T. V. Dokukina, F. P. Khlebokazov, I. I. Khvostova, N. N. Misyuk, K. A. Bondar, P. P. Korolevich, E. L. Slobina, I. S. Glavinskiy

Get full text

OUR EXPERIENCE IN APPLICATION OF AUTOLOGOUS BONE-MARROW-DERIVED MESENCHYMAL STEM CELLS FOR THERAPY OF PATIENTS WITH SYMPTOMATIC EPILEPSY by F. P. Hlebokazov, T. V. Dоkukina, S. I. Ighnatenko, S. M. Кosmacheva, N. V. Goncharova, M. P. Potapnev, M. V. Makhrov, P. P. Korolevich, N. N. Misyuk, I. V. Grigorieva, S. A. Marchuk

Get full text

CELL THERAPY OF EPILEPSIA. CLINICAL AND IMMUNOLOGICAL ASPECTS by T. V. Dokukina, M. P. Potapnev, S. M. Kosmacheva, F. P. Hlebokazov, E. L. Slobina, T. S. Golubeva, N. N. Misjuk, M. V. Mahrov, I. V. Shamruk, P. P. Korolevich, A. I. Martynenko, I. V. Bychenko, T. O. Bud’ko

Get full text